EPO-loaded gelatin patch decreases MI size myocardial infarct size
This article was originally published in Clinica
In what could provide a new therapeutic strategy for ischaemic heart disease, a Japanese team has found that an erythropoietin (EPO)-loaded gelatin hydrogel sheet applied to the myocardial surface could reduce infarct size.
You may also be interested in...
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.
Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and bottom lines in 2019.